Meet the ACGT Team
The Advanced Center for Genetic Therapies (ACGT) was created to advance progress in the care and treatment of patients with genetic conditions through the support of high-quality, high-impact clinical research. To this end, the ACGT focuses on the development and operation of clinical research studies in many genetic conditions, particularly those in phase II-IV of development. The ACGT is cooperatively led by Medical Director William R. Wilcox, MD, PhD and Director Dawn Laney, MS, CGC, CCRC under the oversight of Division Chief Michael Gambello, MD, PhD.
